Genetic Modifiers of Venous Thrombosis

Loading...
Thumbnail Image

Authors

Plummer, Jesse

Issue Date

2009-05-06T19:39:39Z

Type

Presentation

Language

en_US

Keywords

Research Projects

Organizational Units

Journal Issue

Alternative Title

Abstract

Venous thrombosis (VT) is defined as the formation of a blood clot within a vein. VT occurs in approximately 1 in 1000 people per year. Many genetic and environmental risk factors have been linked to the development of VT. Because of this, it is helpful to consider a “pro-blood clotting threshold”, which must be reached in order for a pathologic clot to occur. This threshold relies on a delicate balance between factors favoring clot formation and factors promoting clot dissolution (fibrinolysis) (figure 1). A mutation in the factor V gene, Factor V Leiden, is the most common known inherited risk factor for VT. However, penetrance is incomplete, only ~10% of FVL carriers experience significant blood clotting. It would be of great benefit to find additional genetic modifiers of FVL as well as thrombosis in general. This would allow for a more accurate risk assessment and potentially lead to new therapies for thrombosis patients. In order to identify modifying genes to VT, we will perform a ‘forward’ genetic screen in mice, for genes capable of suppression of a synthetic genotype that is normally lethal due to blood clotting. Any gene responsible for the suppression will be considered a candidate modifier gene to VT, and presumably a factor of the coagulation cascade. We previously generated a lethal interaction between FVL and another key coagulation factor, tissue factor pathway inhibitor (TFPI) in mice. When TFPI heterozygosity (Tfpi+/-) is combined with homozygosity for FVL (FvQ/Q), the result is neonatal lethality due to blood clotting. We have exploited this FVL/TFPI interaction as a phenotyping tool for a whole genome ENU mutagenesis screen in mice, in an attempt to identify ENU-induced thrombotic modifiers. Once suppressing genes are induced, positional cloning techniques will be done to locate and identify the genes responsible.

Description

1 broadside

Citation

Publisher

License

U.S. copyright laws protect this material. Commercial use or distribution of this material is not permitted without prior written permission of the copyright holder.

Journal

Volume

Issue

PubMed ID

DOI

ISSN

EISSN